Skip to Content
  • Previous Rank
    145
  • Revenues ($M)
    $22,561.0
  • Revenue Percent Change
    8.6%
  • Profits ($M)
    $4,920.0
  • Profits Percent Change
    388.6%
  • Assets ($M)
    $34,986.0
  • Employees
    23,300

The biopharmaceutical company manufactures medicines for Alzheimer’s, dementia, psychiatric disorders, cardiovascular, diabetes, oncology, and hepatitis.

Created with sketchtool.Created with sketchtool.Looking for leads, investment insights, or competitive intelligence?Buy Now

Company Info

CEO
Giovanni Caforio
CEO Title
Chairman & Chief Executive Officer
Sector
Health Care
Industry
Pharmaceuticals
HQ Location
New York, N.Y.
Websitehttp://www.bms.com
Years on Fortune 500 List65
Employees23,300

Bristol-Myers Squibb Rank History

placeholder

Key Financials (Last Fiscal Year)

$ millions% change
Revenues ($M)$22,561.08.6%
Profits ($M)$4,920.0388.6%
Assets ($M)$34,986.0-
Total Stockholder Equity ($M)$14,031.0-

Profit Ratios

Profit as % of Revenues21.8%
Profits as % of Assets14.1%
Profits as % of Stockholder Equity35.1%

Earnings Per Share (Last Fiscal Year)

Earnings Per Share ($)3.01
EPS % Change (from 2017)393.4%
EPS % Change (5 year annual rate)14.3%
EPS % Change (10 year annual rate)1.4%

Total Return

Total Return to Investors (2018)-12.7%
Total Return to Investors (5 year, annualized)2.2%
Total Return to Investors (10 year, annualized)12.3%